Springer to acquire BioMed Central Group

Springer Science+Business Media has reached an agreement to acquire BioMed Central Group, the leading global open access publisher. BioMed Central was launched in May 2000 as an independent publishing house committed to providing free access to peer-reviewed research in the biological and medical sciences. BMC is the largest open access provider in the world with over 180 peer-reviewed journals. BioMed Central's flagship journals include Journal of Biology, BMC Biology, BMC Medicine, Malaria Journal, BMC Bioinformatics and Genome Biology. BioMed Central has revenues of approximately EUR 15 million per year. The company is based in London, with a second office in Liverpool, and has approximately 150 employees. Derk Haank, CEO of Springer Science+Business Media said: 'This acquisition reinforces the fact that we see open access publishing as a sustainable part of STM publishing, and not an ideological crusade. We have gained considerable positive experience since starting Springer Open Choice in 2004, and BioMed Central's activities are complementary to what we are doing. Additionally, this acquisition strengthens Springer's position in the life sciences and biomedicine, and will allow us to offer societies a greater range of publishing options."